3 Oil Refining and Marketing Company, Branded Jeans Apparel Company and Research Driven Pharma Company Stocks With a Strong Future Roadmap: Bharat Petroleum, Kewal Kiran Clothing and Glenmark Pharmaceuticals
- November 5, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Bharat Petroleum, Kewal Kiran Clothing and Glenmark Pharmaceuticals: ROE of 15.4% to 28.1% and FY22 to FY26 revenue CAGR of 7.1% to 18.6%. Prices as of 4 Nov 2026.
Quick Answer
The three fuel retailer, jeans brand and drug stocks to watch are Bharat Petroleum, Kewal Kiran Clothing and Glenmark Pharmaceuticals. Their return on equity ranges from 15.4% to 28.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.1% to 18.6%. Glenmark Pharmaceuticals has the highest return on equity at 28.1%, while Kewal Kiran Clothing has the fastest revenue growth at 18.6% a year. Prices are based on the 4 November 2026 close, and this article is educational, not investment advice.
Fuel retailer, jeans brand and drug stocks bring together companies with a visible plan for the years ahead. Bharat Petroleum, Kewal Kiran Clothing and Glenmark Pharmaceuticals cover an oil refining and marketing company, a branded jeans apparel company and a research driven pharma company.
This list covers three fuel retailer, jeans brand and drug stocks with complete current figures: Bharat Petroleum, Kewal Kiran Clothing and Glenmark Pharmaceuticals. Every figure comes from the latest reported financials and the 4 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Fuel Retailer, Jeans Brand and Drug Stocks?
Fuel retailer, jeans brand and drug stocks are listed companies that refine crude oil and sell petrol, diesel and cooking gas, own denim and casual wear brands, and sell branded generics and specialty medicines in India and overseas. Their earnings depend on fuel consumption, apparel demand and drug approvals.
Fuel Retailer, Jeans Brand and Drug Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Bharat Petroleum | 304.7 | 128,116 | 8.1 | 15.4 | 15.6 | 0.62 |
| Kewal Kiran Clothing | 434.05 | 2,588 | 16.1 | 33.8 | 15.4 | 0.11 |
| Glenmark Pharmaceuticals | 2,504.7 | 60,103 | 33.4 | 35.7 | 28.1 | 0.06 |
On valuation, all three trade at a P/E below their industry P/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing fuel retailer, jeans brand and drug stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Fuel Retailer, Jeans Brand and Drug Stocks Have a Strong Roadmap in India?
Fuel retailer, jeans brand and drug stocks have a strong roadmap in India because steady fuel consumption, rising branded apparel buying and wider demand for specialty medicines keep widening the market for these companies.
- Fuel marketing. A wide outlet network serves growing vehicle use.
- Denim apparel. Brand-conscious youth buy more.
- Pharma. Specialty medicines reach more markets.
Why Bharat Petroleum Features Among These Fuel Retailer, Jeans Brand and Drug Stocks
Among the fuel retailer, jeans brand and drug stocks on this list, Bharat Petroleum Corporation is a public sector oil marketing and refining company that refines crude oil and sells petrol, diesel, cooking gas and lubricants through a nationwide network of fuel stations.
The company has a return on equity of 15.6%, a debt to equity ratio of 0.62 and a market capitalisation of Rs 128,116 crore. The stock trades at a P/E of 8.1, below the industry P/E of 15.4.
Revenue rose from Rs 349,060 crore in FY22 to Rs 458,527 crore in FY26, a compound annual growth rate of 7.1%. Net profit grew from Rs 11,682 crore in FY22 to Rs 25,843 crore in FY26, which works out to a compound annual growth rate of 22.0%.
Roadmap: The company is expanding its refining and petrochemical capacity and building a presence in gas, renewable energy and electric vehicle charging. A large retail fuel network gives it steady demand across the country.
What to watch: Follow refining margins, fuel demand and progress on new capacity.
Why Kewal Kiran Clothing Features Among These Fuel Retailer, Jeans Brand and Drug Stocks
Among the energy, apparel and pharma shares on this list, Kewal Kiran Clothing, based in Mumbai, owns the Killer, Easies, Integriti and Lawman Pg3 brands and sells jeanswear and casual apparel through exclusive stores, multi-brand outlets and online channels.
Revenue rose from Rs 625 crore in FY22 to Rs 1,237 crore in FY26, a compound annual growth rate of 18.6%. Net profit grew from Rs 81.6 crore in FY22 to Rs 152 crore in FY26, which works out to a compound annual growth rate of 16.9%.
In the June 2026 quarter, revenue grew 17.9% year on year to Rs 292 crore, while net profit rose 28.2% to Rs 41.0 crore. The company has a return on equity of 15.4%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 2,588 crore. The stock trades at a P/E of 16.1, below the industry P/E of 33.8.
Roadmap: The company is widening its exclusive store network, building its newer brands and adding product categories beyond denim. Control over its own manufacturing helps it respond quickly to fashion trends, and a debt-light balance sheet supports store expansion.
What to watch: Follow same-store sales and the pace at which newer brands scale.
Why Glenmark Pharmaceuticals Features Among These Fuel Retailer, Jeans Brand and Drug Stocks
Among the three companies on this list, Glenmark Pharmaceuticals is a research-driven pharma company with branded generics in India and other emerging markets, generics in the United States and Europe, and an innovation arm focused on new drugs.
In the June 2026 quarter, revenue grew 24.1% year on year to Rs 4,084 crore. Revenue rose from Rs 12,472 crore in FY22 to Rs 17,443 crore in FY26, a compound annual growth rate of 8.7%.
Net profit grew from Rs 994 crore in FY22 to Rs 1,362 crore in FY26, which works out to a compound annual growth rate of 8.2%. The company has a return on equity of 28.1%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 60,103 crore. The stock trades at a P/E of 33.4, below the industry P/E of 35.7.
Roadmap: The company is strengthening its dermatology and respiratory franchises and advancing its innovation pipeline, which could add higher-value income. Growth in India and emerging markets supports steady sales.
What to watch: Track new product launches, progress in the innovation pipeline and balance sheet strength.
Bharat Petroleum vs Kewal Kiran Clothing vs Glenmark Pharmaceuticals on Key Financials
The table below sets the three fuel retailer, jeans brand and drug stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Bharat Petroleum | 349,060 | 458,527 | 7.1% | 25,843 | 5.6% |
| Kewal Kiran Clothing | 625 | 1,237 | 18.6% | 152 | 12.3% |
| Glenmark Pharmaceuticals | 12,472 | 17,443 | 8.7% | 1,362 | 7.8% |
Glenmark Pharmaceuticals posts the highest return on equity in this group at 28.1%. Bharat Petroleum has the largest FY26 revenue at Rs 458,527 crore, and Kewal Kiran Clothing shows the fastest revenue growth with a 18.6% compound annual rate. A useful habit with fuel retailer, jeans brand and drug stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Fuel Retailer, Jeans Brand and Drug Stocks
Every theme carries risks that deserve a check before any decision. For these fuel retailer, jeans brand and drug stocks, the main points are: Long-term energy, apparel and pharma shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Fuel and power prices. Tariffs and fuel costs can influence earnings.
- Consumer spending. Sales follow festivals, incomes and consumer mood.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter fuel retailer, jeans brand and drug stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Fuel Retailer, Jeans Brand and Drug Stocks
Fuel retailer, jeans brand and drug stocks suit investors who prefer to study business strength before price moves. Bharat Petroleum, Kewal Kiran Clothing and Glenmark Pharmaceuticals each have a clear plan to grow. Based on the 4 November 2026 close, Bharat Petroleum trades at Rs 304.7, Kewal Kiran Clothing at Rs 434.05 and Glenmark Pharmaceuticals at Rs 2,504.7. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these fuel retailer, jeans brand and drug stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track fuel retailer, jeans brand and drug stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are fuel retailer, jeans brand and drug stocks?
Ans. Fuel retailer, jeans brand and drug stocks are listed companies that refine crude oil and sell petrol, diesel and cooking gas, own denim and casual wear brands, and sell branded generics and specialty medicines in India and overseas. Their earnings depend on fuel consumption, apparel demand and drug approvals. This list looks at three of them, Bharat Petroleum, Kewal Kiran Clothing and Glenmark Pharmaceuticals, using reported FY22 to FY26 financials and the 4 November 2026 closing prices.
Which fuel retailer, jeans brand and drug stocks are covered in this list?
Ans. This list covers Bharat Petroleum, Kewal Kiran Clothing and Glenmark Pharmaceuticals. Based on the 4 November 2026 close, Bharat Petroleum traded at Rs 304.7, Kewal Kiran Clothing at Rs 434.05 and Glenmark Pharmaceuticals at Rs 2,504.7. Their return on equity ranges from 15.4% to 28.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.1% to 18.6%.
Why do fuel retailer, jeans brand and drug stocks have a strong future roadmap in India?
Ans. Fuel retailer, jeans brand and drug stocks have a strong roadmap in India because steady fuel consumption, rising branded apparel buying and wider demand for specialty medicines keep widening the market for these companies. The main drivers are as follows. Fuel marketing. A wide outlet network serves growing vehicle use. Denim apparel. Brand-conscious youth buy more. Pharma. Specialty medicines reach more markets. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Bharat Petroleum performed financially?
Ans. Revenue rose from Rs 349,060 crore in FY22 to Rs 458,527 crore in FY26, a compound annual growth rate of 7.1%. Net profit grew from Rs 11,682 crore in FY22 to Rs 25,843 crore in FY26, which works out to a compound annual growth rate of 22.0%. The company has a return on equity of 15.6%, a debt to equity ratio of 0.62 and a market capitalisation of Rs 128,116 crore. The stock trades at a P/E of 8.1, below the industry P/E of 15.4. Looking ahead, the company is expanding its refining and petrochemical capacity and building a presence in gas, renewable energy and electric vehicle charging. A large retail fuel network gives it steady demand across the country.
How has Kewal Kiran Clothing performed financially?
Ans. Revenue rose from Rs 625 crore in FY22 to Rs 1,237 crore in FY26, a compound annual growth rate of 18.6%. Net profit grew from Rs 81.6 crore in FY22 to Rs 152 crore in FY26, which works out to a compound annual growth rate of 16.9%. In the June 2026 quarter, revenue grew 17.9% year on year to Rs 292 crore, while net profit rose 28.2% to Rs 41.0 crore. The company has a return on equity of 15.4%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 2,588 crore. The stock trades at a P/E of 16.1, below the industry P/E of 33.8. Looking ahead, the company is widening its exclusive store network, building its newer brands and adding product categories beyond denim. Control over its own manufacturing helps it respond quickly to fashion trends, and a debt-light balance sheet supports store expansion.
How has Glenmark Pharmaceuticals performed financially?
Ans. Revenue rose from Rs 12,472 crore in FY22 to Rs 17,443 crore in FY26, a compound annual growth rate of 8.7%. Net profit grew from Rs 994 crore in FY22 to Rs 1,362 crore in FY26, which works out to a compound annual growth rate of 8.2%. In the June 2026 quarter, revenue grew 24.1% year on year to Rs 4,084 crore. The company has a return on equity of 28.1%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 60,103 crore. The stock trades at a P/E of 33.4, below the industry P/E of 35.7. Looking ahead, the company is strengthening its dermatology and respiratory franchises and advancing its innovation pipeline, which could add higher-value income. Growth in India and emerging markets supports steady sales.
What risks should investors check before buying fuel retailer, jeans brand and drug stocks?
Ans. Investors should check a few risks before buying fuel retailer, jeans brand and drug stocks. Fuel and power prices. Tariffs and fuel costs can influence earnings. Consumer spending. Sales follow festivals, incomes and consumer mood. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of fuel retailer, jeans brand and drug stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 4 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
